Abstract
Microspheres offer the possibility of local noninvasive delivery of drugs over an extended period of time. We adsorbed fibroblast growth factor (FGF) to microspheres of precapillary size that were injected via a coronary catheter. We showed that FGF was released from these microspheres and taken up by endothelial cells, which proliferated following translocation of FGF to the nucleus. This method for application of growth factors allows the precise delivery of angiogenic substances to any selected part of the heart or other organs without causing inflammation or ischemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Banai, S., Jaklitsch, M.T., Casscells, W., Shou, M., Shrivastav, S., Correa R., et al. 1991. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ. Res. 69: 76–85.
Banai, S., Jaklitsch, M.T., Shou, M., Lazarous, D.F., Scheinowitz, M., Biro, S., et al1994. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183–2189.
Battler, A., Scheinowitz, M., Bor, A., Hasdai, D., Vered, Z., Di Segni, E., et al. 1993. Intracoronary injection of basic fibroblast growth factor enhances angio-genesis in infarcted swine myocardium. J. Am. Coll. Cardiol. 22: 2001–2006.
Bauters, C., Asahara, T., Zheng, L.P., Takeshita, S., Bunting, S., Ferrara, N., et al. 1994. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267: H1263–H1271.
Harada, K., Grossman, W., Friedman, M., Edelman, E.R., Prasad, P.V., Keighley, C.S., et al. 1994.Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. 94: 623–630.
Lazarous, D.F., Shou, M., Scheinowitz, M., Hodge, E., Thirumurti, V., Kitsiou, A.N., et al. 1996. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94: 1074–1082.
Takeshita, S., Zheng, L.P, Brogi, E., Kearney, M., Pu, L.-Q., Bunting, S., et al.1994. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93: 662–670.
Unger, E.F., Banai, S., Shou, M., Lazarous, D.F., Jaklitsch, M.T., Sheinowitz, M., et al. 1994. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 266: H1588–1595.
Denefle, P., Duverger, N., and Branellec, D . 1995. Genetic therapies for vascular diseases and lipid disorders. Expert Opinion on Investigational Drugs 4: 1129–1137.
Mulligan, R.C. 1993. The basic science of gene therapy. Science 260: 926–931.
Gilgenkrantz, H., Duboc, D., Juillard, V., Couton, D., Pavirani, A., Guillet, J.G., et al. 1995. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum. Gene Ther. 6: 1265–1274.
Landau, C., Pirwitz, M.J., Willard, M.A., Gerard, R.D., Meidell, R.S., and Willard, J.E. 1995. Adenoviral mediated gene transfer to atherosclerotic arteries after balloon angioplasty. Am. Heart J. 129: 1051–1057.
Ueno, H., Li, J.J., Tomita, H.H.Y., Pan, Y., Kanegae, Y., Saito, I., and Takeshita, A. 1995. Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler. Thromb. Vase. Biol. 15: 2246–2253.
Ueno, H., Pan, Y.H.T., Yamamoto, H.Y.K., Saito, I., Takeshita, A. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc. Res. 1995; 30: 97–105.
Lew, D., Parker, S.E., Latimer, T., Abai, A.M., Kuwahara Rundell, A., Doh, S.G., et al. 1995. Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6: 553–564.
Johnson, O.L., Cleland, J.L., Lee, H.J., Charnis, M., Duenas, E., Jaworowicz, W., et al. 1996. A month-long effect from a single injection of miroencapsulated human growth hormone. Nat. Med. 2: 795–799.
Schaper, W., Görge, G., Winkler, B., and Schaper, J. 1988. The collateral circulation of the heart. Prog. Cardiovasc. Dis. 31: 57–77.
Baldin, V., Roman, A.-M., Bosc-Bierne, I., Amalric, F., and Bouche, G. 1990. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J. 9: 1511–1517.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arras, M., Mollnau, H., Strasser, R. et al. The delivery of angiogenic factors to the heart by microsphere therapy. Nat Biotechnol 16, 159–162 (1998). https://doi.org/10.1038/nbt0298-159
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0298-159
This article is cited by
-
Collateral circulation
Basic Research in Cardiology (2009)
-
Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres
Gene Therapy (2006)
-
Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF‐2)
British Journal of Pharmacology (2003)
-
Gene transfer as a tool to induce therapeutic vascular growth
Nature Medicine (2003)
-
Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia
Gene Therapy (2001)